Trademark: 97698550
Word
UGSH
Status Date
Tuesday, June 4, 2024
Filing Date
Wednesday, November 30, 2022
Published for Opposition
Tuesday, October 10, 2023
5 Gene therapy products, namely, custom donor genetic material in the nature of human cells for use in genome modification for medical or clinical use; Biological preparations for use in the genetic treatment of pathological medical conditions, namely, cancer, neurological diseases, autoimmune diseases, and genetic disorders
Dec 3, 2022
New Application Entered
Dec 24, 2022
New Application Office Supplied Data Entered
Aug 24, 2023
Assigned To Examiner
Sep 1, 2023
Examiners Amendment -Written
Sep 1, 2023
Examiners Amendment E-Mailed
Sep 1, 2023
Notification Of Examiners Amendment E-Mailed
Sep 1, 2023
Examiner's Amendment Entered
Sep 1, 2023
Approved For Pub - Principal Register
Sep 20, 2023
Notification Of Notice Of Publication E-Mailed
Oct 10, 2023
Published For Opposition
Oct 10, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 5, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 4, 2024
Sou Teas Extension Received
Jun 4, 2024
Sou Extension 1 Filed
Jun 4, 2024
Sou Extension 1 Granted
Jun 13, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
